A citation-based method for searching scientific literature

Lynn C Hartmann, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh. N Engl J Med 2015
Times Cited: 172







List of co-cited articles
605 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Lynn C Hartmann, Derek C Radisky, Marlene H Frost, Richard J Santen, Robert A Vierkant, Lorelle L Benetti, Yaman Tarabishy, Karthik Ghosh, Daniel W Visscher, Amy C Degnim. Cancer Prev Res (Phila) 2014
113
30


Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005
532
19

Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Amy C Degnim, Daniel W Visscher, Hal K Berman, Marlene H Frost, Thomas A Sellers, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Piet C de Groen, Wilma L Lingle,[...]. J Clin Oncol 2007
156
16

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Alvaro Peña, Sejal S Shah, Robert T Fazzio, Tanya L Hoskin, Rushin D Brahmbhatt, Tina J Hieken, James W Jakub, Judy C Boughey, Daniel W Visscher, Amy C Degnim. Breast Cancer Res Treat 2017
43
37

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
D L Page, W D Dupont, L W Rogers, M S Rados. Cancer 1985
743
14

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
14

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011
592
13

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
13

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
862
12

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy.
Tehillah S Menes, Karla Kerlikowske, Jane Lange, Shabnam Jaffer, Robert Rosenberg, Diana L Miglioretti. JAMA Oncol 2017
29
41

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
Tari A King, Melissa Pilewskie, Shirin Muhsen, Sujata Patil, Starr K Mautner, Anna Park, Sabine Oskar, Elena Guerini-Rocco, Camilla Boafo, Jessica C Gooch,[...]. J Clin Oncol 2015
99
12

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.
Suzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, John Sharko, Ahmet K Belli, Elizabeth M H Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E Garber, Barbara L Smith,[...]. Breast Cancer Res Treat 2012
78
15

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
Tanjina Kader, Prue Hill, Emad A Rakha, Ian G Campbell, Kylie L Gorringe. Breast Cancer Res 2018
24
50


Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
404
11

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.
David L Page, Peggy A Schuyler, William D Dupont, Roy A Jensen, W Dale Plummer, Jean F Simpson. Lancet 2003
200
10

Current management of lesions associated with an increased risk of breast cancer.
Monica Morrow, Stuart J Schnitt, Larry Norton. Nat Rev Clin Oncol 2015
65
15

Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.
Christopher V Nguyen, Constance T Albarracin, Gary J Whitman, Adriana Lopez, Nour Sneige. Ann Surg Oncol 2011
71
14

Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
Lee J McGhan, Barbara A Pockaj, Nabil Wasif, Marina E Giurescu, Ann E McCullough, Richard J Gray. Ann Surg Oncol 2012
62
16

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
10

Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.
Samar M Said, Daniel W Visscher, Aziza Nassar, Ryan D Frank, Robert A Vierkant, Marlene H Frost, Karthik Ghosh, Derek C Radisky, Lynn C Hartmann, Amy C Degnim. Cancer 2015
44
22

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
357
10

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
289
10

Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.
Jennifer R Kohr, Peter R Eby, Kimberly H Allison, Wendy B DeMartini, Robert L Gutierrez, Sue Peacock, Constance D Lehman. Radiology 2010
74
12

Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia.
Rhiana S Menen, Nivetha Ganesan, Therese Bevers, Jun Ying, Robin Coyne, Deanna Lane, Constance Albarracin, Isabelle Bedrosian. Ann Surg Oncol 2017
27
33

The molecular pathology of breast cancer progression.
Alessandro Bombonati, Dennis C Sgroi. J Pathol 2011
231
9

Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge.
Peter R Eby, Jennifer E Ochsner, Wendy B DeMartini, Kimberly H Allison, Sue Peacock, Constance D Lehman. AJR Am J Roentgenol 2009
65
12


A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
717
8

First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Christoph J Rageth, Elizabeth Am O'Flynn, Christopher Comstock, Claudia Kurtz, Rahel Kubik, Helmut Madjar, Domenico Lepori, Gert Kampmann, Alexander Mundinger, Astrid Baege,[...]. Breast Cancer Res Treat 2016
86
9

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013
212
8

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Valerie A McCormack, Isabel dos Santos Silva. Cancer Epidemiol Biomarkers Prev 2006
8

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Miraj G Shah-Khan, Xochiquetzal J Geiger, Carol Reynolds, James W Jakub, Elizabeth R Deperi, Katrina N Glazebrook. Ann Surg Oncol 2012
65
10

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
Amy C Degnim, William D Dupont, Derek C Radisky, Robert A Vierkant, Ryan D Frank, Marlene H Frost, Stacey J Winham, Melinda E Sanders, Jeffrey R Smith, David L Page,[...]. Cancer 2016
32
21

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
Daniel W Visscher, Marlene H Frost, Lynn C Hartmann, Ryan D Frank, Robert A Vierkant, Ann E McCullough, Stacey J Winham, Celine M Vachon, Karthik Ghosh, Kathleen R Brandt,[...]. Cancer 2016
21
33

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.
Tehillah S Menes, Robert Rosenberg, Steven Balch, Shabnam Jaffer, Karla Kerlikowske, Diana L Miglioretti. Am J Surg 2014
50
14

Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.
Sara W Dyrstad, Yan Yan, Amy M Fowler, Graham A Colditz. Breast Cancer Res Treat 2015
73
9

Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.
Ikechukwu Uzoaru, Bradley R Morgan, Zheng G Liu, Frank J Bellafiore, Farah S Gaudier, Jeanne V Lo, Kourosh Pakzad. Virchows Arch 2012
42
16

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
7

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
7

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
255
7

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
69
10

Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Christoph J Rageth, Elizabeth A M O'Flynn, Katja Pinker, Rahel A Kubik-Huch, Alexander Mundinger, Thomas Decker, Christoph Tausch, Florian Dammann, Pascal A Baltzer, Eva Maria Fallenberg,[...]. Breast Cancer Res Treat 2019
107
7

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
Melissa P Murray, Chad Luedtke, Laura Liberman, Tatjana Nehhozina, Muzaffar Akram, Edi Brogi. Cancer 2013
80
7

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2007
93
6



An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.
Jason T Lewis, Lynn C Hartmann, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Teresa M Allers, Marlene H Frost, Daniel W Visscher. Am J Surg Pathol 2006
110
6

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
199
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.